The leading PD-1+ NSCLC Companies such as Arcus Biosciences, Akeso Biopharma, Biotheus, GlaxoSmithKline, AstraZeneca, Pfizer, Shandong Boan Biotechnology, Genor Biopharma and others. Promising PD-1+ ...

Absci has entered the clinic with its AI-designed antibody, dosing first volunteers in a trial targeting TL1A for ...

Fintel reports that on May 28, 2025, Wedbush downgraded their outlook for iTeos Therapeutics (NasdaqGM:ITOS) from Outperform ...

Fintel reports that on May 28, 2025, Wells Fargo downgraded their outlook for iTeos Therapeutics (NasdaqGM:ITOS) from ...

Eli Lilly and Company today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at ...

⊥ ⊥ Department of Entomology and Cancer Research Center, and # Pulmonary/Critical Care Medicine, School of Medicine, University of California, Davis, Davis, California, United States Article Views are ...

The global Healthcare Contract Manufacturing Market size is projected to be valued at USD 183.7 billion in 2023 and reach USD 347.5 billion by 2030, growing ...

We welcome sponsors for the congress. If you are interested in becoming a sponsor of this congress, please do not hesitate to contact Raimond Heukers for more information on the possibilities.

The biopharmaceutical contract manufacturing market is expected to grow at a CAGR of 8.8% during the projected period. The ...

Monoclonal antibodies against SARS-CoV-2 were considered a promising approach for the prevention and therapy of coronavirus ...